Zoetis Inc. ZTS | NYSE
Next Earnings: Jul 31, 2026
Company Overview:
10 Year ZTS Performance Metrics:
ZTS Dividend Payments, Yield & Share Price charts
Unlock All Reports & Research Dividend Stocks.
[lev_ptables no_sale]ZTS Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.
ZTS Earnings, Revenue, Cash & Debt, Shares Outstaning:
Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:
Ratios, Profit Margins & Return on Capital:
ZTS Dividends Info:
ZTS Dividend History: Dates, Payments & Yield list
Below is a schedule of all ZTS dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield
| Ex-Date | Payment Date | Amount | TTM Yield | Forward Yield | Price on Ex-Date |
|---|---|---|---|---|---|
| 07/20/2026 | 09/01/2026 | $0.530 | 2.74% | 0% | $0.00 |
| 04/20/2026 | 06/02/2026 | $0.530 | 1.68% | 2.78% | $76.39 |
| 01/20/2026 | 03/03/2026 | $0.530 | 1.65% | 1.68% | $125.93 |
| 10/31/2025 | 12/02/2025 | $0.500 | 1.39% | 1.61% | $124.44 |
| 07/18/2025 | 09/03/2025 | $0.500 | 1.3% | 1.31% | $152.43 |
| 04/21/2025 | 06/03/2025 | $0.500 | 1.27% | 1.17% | $170.30 |
| 01/21/2025 | 03/04/2025 | $0.500 | 1.07% | 1.18% | $169.90 |
| 10/31/2024 | 12/03/2024 | $0.432 | 0.97% | 0.98% | $176.94 |
| 07/18/2024 | 09/04/2024 | $0.432 | 0.93% | 0.92% | $187.33 |
| 04/18/2024 | 06/04/2024 | $0.432 | 1.05% | 1.01% | $171.88 |
| 01/18/2024 | 03/01/2024 | $0.432 | 0.82% | 0.91% | $190.82 |
| 10/31/2023 | 12/01/2023 | $0.375 | 0.96% | 0.84% | $179.13 |
| 07/20/2023 | 09/01/2023 | $0.375 | 0.84% | 0.78% | $192.52 |
| 04/20/2023 | 06/01/2023 | $0.375 | 0.62% | 0.9% | $166.00 |
| 01/19/2023 | 03/01/2023 | $0.375 | 0.43% | 0.9% | $167.57 |
| 10/31/2022 | 12/01/2022 | $0.325 | 0.86% | 0.83% | $156.64 |
| 07/20/2022 | 09/01/2022 | $0.325 | 0.7% | 0.82% | $159.41 |
| 04/20/2022 | 06/01/2022 | $0.325 | 0.61% | 0.78% | $167.02 |
| 01/19/2022 | 03/01/2022 | $0.325 | 0.54% | 0.68% | $192.54 |
| 10/28/2021 | 12/01/2021 | $0.250 | 0.47% | 0.46% | $219.66 |
| 07/20/2021 | 09/01/2021 | $0.250 | 0.47% | 0.48% | $206.44 |
| 04/20/2021 | 06/01/2021 | $0.250 | 0.53% | 0.57% | $174.19 |
| 01/19/2021 | 03/01/2021 | $0.250 | 0.52% | 0.63% | $157.69 |
| 10/20/2020 | 12/01/2020 | $0.200 | 0.5% | 0.5% | $161.36 |
| 07/16/2020 | 09/01/2020 | $0.200 | 0.53% | 0.49% | $162.05 |
| 04/16/2020 | 06/01/2020 | $0.200 | 0.57% | 0.58% | $138.34 |
| 01/16/2020 | 03/03/2020 | $0.200 | 0.5% | 0.58% | $137.24 |
| 10/21/2019 | 12/02/2019 | $0.164 | 0.52% | 0.55% | $119.91 |
| 07/18/2019 | 09/03/2019 | $0.164 | 0.54% | 0.52% | $127.04 |
| 04/17/2019 | 06/03/2019 | $0.164 | 0.59% | 0.63% | $103.95 |
| 01/17/2019 | 03/01/2019 | $0.164 | 0.64% | 0.69% | $95.75 |
| 11/19/2018 | 12/03/2018 | $0.126 | 0.56% | 0.54% | $93.57 |
| 07/19/2018 | 09/04/2018 | $0.126 | 0.57% | 0.56% | $89.97 |
| 04/19/2018 | 06/01/2018 | $0.126 | 0.54% | 0.59% | $85.42 |
| 01/18/2018 | 03/01/2018 | $0.126 | 0.58% | 0.63% | $80.44 |
| 11/08/2017 | 12/01/2017 | $0.105 | 0.6% | 0.58% | $72.30 |
| 06/13/2017 | 09/01/2017 | $0.105 | 0.66% | 0.67% | $62.87 |
| 04/04/2017 | 06/01/2017 | $0.105 | 0.76% | 0.67% | $62.64 |
| 01/18/2017 | 03/01/2017 | $0.105 | 0.73% | 0.78% | $53.89 |
| 11/01/2016 | 12/01/2016 | $0.095 | 0.8% | 0.77% | $49.16 |
| 06/28/2016 | 08/30/2016 | $0.095 | 0.79% | 0.75% | $50.75 |
| 04/05/2016 | 06/01/2016 | $0.095 | 0.78% | 0.79% | $47.85 |
| 01/19/2016 | 03/01/2016 | $0.095 | 0.8% | 0.9% | $42.10 |
| 11/03/2015 | 12/01/2015 | $0.083 | 0.71% | 0.71% | $47.01 |
| 08/11/2015 | 09/01/2015 | $0.083 | 0.67% | 0.75% | $43.98 |
| 04/07/2015 | 06/02/2015 | $0.083 | 0.67% | 0.67% | $49.58 |
| 01/20/2015 | 03/03/2015 | $0.083 | 0.69% | 0.71% | $46.54 |
| 11/03/2014 | 12/02/2014 | $0.072 | 0.76% | 0.64% | $44.74 |
| 08/18/2014 | 09/02/2014 | $0.072 | 0.83% | 0.81% | $35.48 |
| 04/24/2014 | 06/02/2014 | $0.072 | 0.92% | 0.93% | $30.92 |
| 01/28/2014 | 03/04/2014 | $0.072 | 0.85% | 0.93% | $30.89 |
| 10/30/2013 | 12/02/2013 | $0.065 | 0.61% | 0.83% | $31.15 |
| 07/30/2013 | 09/02/2013 | $0.065 | 0.43% | 0.88% | $29.43 |
| 04/29/2013 | 06/06/2013 | $0.065 | 0.2% | 0.81% | $32.08 |
Projected Future Returns & Dividends for ZTS
Based on past 10-year performance, here are ZTS growth metrics:
Share price CAGR of +4.37%
Dividend CAGR of +18.76%
Using ZTS CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:
| ZTS (DRIP) | ZTS - No DRIP | |
|---|---|---|
| Current Price | $77.31 | $77.31 |
| Start Shares | 129.35 | 129.35 |
| Start Value | $10,000 | $10,000 |
| After 10 years: | ||
| Final Share Count | 217.75 | 129.35 |
| Dividends Payment | $2.96 | $2.96 |
| Annual Dividends | $2,575 | $1,530 |
| Yield on cost | 25.75% | 15.30% |
| Share Price | $118.59 | $118.59 |
| Total Dividends | $8,864 | $6,695 |
| Final Value | $25,822 | $22,034 |
NOTE: Above numbers are our estimate based on ZTS's Dividend and Price CAGR over past 10 years.
These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.
We cannot guarantee that your actual returns will meet these estimates.
Get the best Dividend Stock Research Tools:
[lev_ptables no_sale]Company Info
Zoetis Inc. (ZTS) had its IPO on 2013-02-01, and is trader on NYSE stock exchange.
Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents. This includes vaccines, vital for preventing respiratory, gastrointestinal, and reproductive diseases by stimulating a targeted immune response; anti-infectives that combat or inhibit the proliferation of bacterial, fungal, or protozoal pathogens; and parasiticides aimed at eradicating both internal and external pests such as fleas, ticks, and various worms. Additional pharmaceuticals address areas such as pain management and sedation, anti-emesis, reproductive health, and oncology. The portfolio also features dermatological solutions for allergic skin conditions and atopic dermatitis, alongside medicated feed additives specifically designed for livestock. Beyond therapeutics, Zoetis offers an extensive array of diagnostic solutions. These include portable analysis systems for blood and urine, point-of-care testing devices, specialized instruments and reagents, rapid immunoassay kits, comprehensive reference laboratory services, and blood glucose monitoring equipment. Further extending its reach, the company provides supplementary offerings such as nutritional products, agribusiness support services, biodevices, genetic testing, and innovations in precision animal health. Zoetis distributes its diverse product portfolio to a broad customer base, including veterinary professionals, livestock producers, and retail channels. This distribution occurs directly via its sales representatives and technical specialists, as well as through partnerships with third-party veterinary distributors. Established in 1952, the company maintains its corporate headquarters in Parsippany, New Jersey.
ZTS website: https://www.zoetis.com
